MUC16 and ovarian cancer: In this cohort study of 212 477 patients with measured CA-125 levels, Black patients had a significantly lower odds of having an elevated CA-125 level at ovarian cancer diagnosis compared with White patients after adjusting for stage, comorbidities, and menopausal status.